Government Caps Trade Margins on 137 Anti-Cancer Drugs at 30% of MRP; Patients Stand to Save Over ₹3,500 Crore
New Delhi: In a significant move to make cancer treatment more affordable, the National Pharmaceutical Pricing Authority (NPPA) on 17 October 2026 limited the trade margin on 137 non-scheduled anti-cancer drugs to
